Govt outlines vaccine schedule, says effect begins 14 days after first jab

India will launch its Covid-19 vaccination drive from January 16 with priority to be given to nearly three crore healthcare and frontline workers

Coronavirus, vaccine, covid, drugs, clinical trials
Press Trust of India New Delhi
2 min read Last Updated : Jan 12 2021 | 8:22 PM IST

There will be a gap of 28 days between two doses of COVID-19 vaccine and its effectiveness will begin 14 days after the second dose, the Health Ministry said on Tuesday.

Addressing a press briefing, Union Health Secretary Rajesh Bhushan said vaccine effectiveness will be seen only after 14 days.

"So we urge people to keep following COVID appropriate behaviour," he said. Bhushan said there will be a gap of 28 days between two doses of COVID-19 vaccine.

India will launch its COVID-19 vaccination drive from January 16 with priority to be given to nearly three crore healthcare and frontline workers.

India had recently granted emergency use authorisation to two vaccines, Oxford's Covishield being manufactured by Serum Institute of India and Bharat Biotech's Covaxin. Both vaccines, the statement from the Health Ministry said, have established safety and immunogenicity.

Dr V K Paul member, NITI Aayog member, said these two vaccines have been tested in thousands of people, they are the safest and there is no risk of any significance.

"We should have no doubt that the two vaccines approved are the safest of the vaccines. Both the vaccines have been tested on thousands of people and side-effects are negligible. There is no risk of any significance," he said.

Bhushan said that as said earlier, there will be a sequential rollout of COVID-19 vaccination.

"Healthcare workers (approximately one crore) will be on the top priority, followed by frontline workers (approximately 2 crore) and prioritized age groups (approximately 27 crore). The cost of healthcare workers and frontline workers will be borne by the central government," Bhushan said.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CentreCoronavirus VaccineHealth Ministry

First Published: Jan 12 2021 | 8:04 PM IST

Next Story